反応 #487578
ord-fdc6908d19524ed9b2665ac855ac0b3c
反応方程式
反応物
試薬
反応条件
後処理
- 1その他was consumed (confirmed by HPLC)
- 2workup.STIRRINGthe mixture was stirred 19 hours
- 3濃縮Concentration in vacuo
- 4その他provided a white solid, which
- 5その他partitioned with water
- 6抽出the aqueous layer extracted three times with dichloromethane
- 7洗浄The combined organic layers were washed with brine
- 8乾燥dried over anhydrous magnesium sulfate
- 9ろ過filtered
- 10濃縮concentrated in vacuo
- 11その他to yield a white solid
実験手順
1-(1-(5-cyano-2-(3,5-dichlorophenoxy)phenylsulfonyl)-piperidin-4-yl)-3-(2-morpholinoethyl)urea (22) is prepared according to the following method as an alternative to the method of Example 32. 3-(4-aminopiperidin-1-ylsulfonyl)-4-(3,5-dichlorophenoxy)-benzonitrile (1.002 g), prepared according to Example 1, and carbonyldiimidazole (420 mg, 1.1 eq.) were combined in THF (15 mL) and stirred at room temperature. After 5 hours, starting material was consumed (confirmed by HPLC). 4-(2-aminoethyl)morpholine (512 mg, 2.0 eq.) was added and the mixture was stirred 19 hours. Concentration in vacuo provided a white solid, which was resuspended in dichlormethane, partitioned with water, and the aqueous layer extracted three times with dichloromethane. The combined organic layers were washed with brine, dried over anhydrous magnesium sulfate, filtered and concentrated in vacuo to yield a white solid. Trituration with isopropyl ether yielded a 96% pure product according to HPLC. The powder was suspended in minimal amounts of hot methanol, stirred at 60° C. for 30 minutes, cooled in an ice bath and vacuum filtered to obtain the product as a white powder (831 mg, 60.7% yield, 98% purity).